[HTML][HTML] Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

C Elfgen, C Leo, RA Kubik-Huch, S Muenst, N Schmidt… - Virchows Archiv, 2023 - Springer
The heterogeneous group of B3 lesions in the breast harbors lesions with different
malignant potential and progression risk. As several studies about B3 lesions have been …

B3 lesions of the breast: histological, clinical, and epidemiological aspects: update

Z Varga, P Sinn, A Lebeau - Pathologie (Heidelberg, Germany), 2023 - europepmc.org
B3-Läsionen der Mamma stellen eine heterogene Gruppe von Läsionen mit unsicherem
Malignitätspotenzial dar, welche histologisch klar definierte Diagnosen beinhalten und …

False-Positive and False-Negative Contrast-enhanced Mammograms: Pitfalls and Strategies to Improve Cancer Detection

MB Carnahan, L Harper, PJ Brown, AA Bhatt… - …, 2023 - pubs.rsna.org
Contrast-enhanced mammography (CEM) is a relatively new breast imaging modality that
uses intravenous contrast material to increase detection of breast cancer. CEM combines …

Nipple discharge imaging evaluation with mammography, ultrasound, galactography, and MRI

HL Chung, TB Bevers, RS Legha, ME Speer, HH Tso… - Academic radiology, 2023 - Elsevier
Rationale and Objective To determine the diagnostic yield of various imaging tests used to
evaluate nipple discharge. Materials and Methods A single institution, IRB-approved …

[HTML][HTML] Clinicopathological and imaging features of breast papillary lesions and their association with pathologic nipple discharge

J Oh, JY Park - Diagnostics, 2023 - mdpi.com
No studies have evaluated whether any clinicopathological or imaging characteristics of
breast papillary lesions are associated with pathological nipple discharge (PND). We …

[HTML][HTML] Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis

P Ziółkowski, M Woźniak, A Mansour, Y An… - Breast Cancer …, 2022 - Springer
Background Papillomas of the breast pose challenges for treatment decisions as their risk
for transformation to breast cancer is low but not negligible. To spare low-risk patients the …

Intraductal papilloma on breast biopsy: upstaging rate and implications for practice guidelines

Y Jee, A Bakht, JM Burner, DL Coldren… - The American …, 2022 - journals.sagepub.com
Background The recommendation for management of intraductal papilloma has not been
clearly established and its surgical excision criteria remain controversial. This study …

[HTML][HTML] Distance of Biopsy-Confirmed High-Risk Breast Lesion from Concurrently Identified Breast Malignancy Associated with Risk of Carcinoma at the High-Risk …

J Le, TJ O'Keefe, S Khan, SM Grossi, HY Choi… - Cancers, 2024 - mdpi.com
Simple Summary Incidental intraductal papilloma without atypia (IPA), lobular hyperplasia
(LCIS or ALH), flat epithelial atypia (FEA) and complex sclerosing lesion (CSL) are high-risk …

Papillary neoplasms of the breast: diagnostic features and molecular insights

DS Ross, TM D'Alfonso - Surgical Pathology Clinics, 2022 - surgpath.theclinics.com
Papillary neoplasms of the breast are a heterogeneous group of tumors characterized by
fibrovascular cores lined by epithelium, with or without myoepithelial cells. Papillary …

Solitary Dilated Ducts Revisited: Malignancy Rate and Implications for Management

B Panigrahi, K Fernandes, LA Mullen, E Oluyemi… - Academic radiology, 2023 - Elsevier
Rationale and Objectives A solitary dilated duct (SDD) is a single asymmetrically dilated
breast duct with diameter more than 2 mm. The Breast Imaging Reporting and Data System …